Warning: Your browser doesn't support all of the features in this Web site. Please view our accessibility page for more details.


The Regenerative Medicine Institute (REMEDI) was established in 2004, receiving 19 million euros in funding from the Science Foundation Ireland CSET programme. The Institute now has 70 researchers, and focuses on gene therapy and stem cell research. Core activities include immunology, genomics and proteomics, preclinical models of cardiovascular arthritic diseases, a toxicology core, GMP cell and vector facility and an ethics and outreach programme. A major focus of REMEDI is to apply gene and stem cell research to cardiovascular disease and arthritis in collaboration with investigators in Ireland and overseas.For more information, go to the REMEDI website.
nuigalway.ie
